Martina Fanella
Overview
Explore the profile of Martina Fanella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
372
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lattanzi S, Canafoglia L, Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, et al.
Neurol Ther
. 2025 Mar;
PMID: 40069539
Introduction: Subjects with intellectual disability are usually excluded from clinical trials and there is limited evidence-based guidance for the choice of antiseizure medications in this vulnerable population. The study explored...
2.
Cerulli Irelli E, Fanella M, Chaumette B, Putotto C, Mignot C, Mazzeo A, et al.
Epilepsia
. 2024 Dec;
66(3):859-869.
PMID: 39718534
Objective: This study was undertaken to characterize the clinical and genetic features of patients with 22q11.2 deletion syndrome (22q11.2DS) and generalized epilepsy compared with 22q11.2DS individuals without epilepsy. Methods: This...
3.
Accinni T, Frascarelli M, Cordellieri P, Kotzalidis G, Fanella M, Di Bonaventura C, et al.
J Intellect Disabil Res
. 2024 Nov;
69(3):177-192.
PMID: 39614621
Background: The 22q11.2 deletion syndrome (22q11.2DS) entails intellectual disabilities and higher risk of psychotic disorders. Neurocognitive deficits predict real-life functioning of schizophrenic patients. We investigated real-life functioning in 22q11.2DS, aiming...
4.
Accinni T, Buzzanca A, Frascarelli M, Carlone L, Ghezzi F, Kotzalidis G, et al.
Schizophr Bull Open
. 2024 Aug;
3(1):sgab049.
PMID: 39144801
Background: 22q11.2 Deletion Syndrome (22q11DS) represents one of the most important genetic risk factors for schizophrenia (SCZ) and a reliable biological model to study endophenotypic characters of SCZ. The aim...
5.
Fanella M, Cerulli Irelli E, Accinni T, Di Fabio F, Putotto C, Pulvirenti F, et al.
Mov Disord Clin Pract
. 2024 Apr;
11(7):808-813.
PMID: 38661486
Background: 22q11.2 deletion syndrome (22q11.2DS) has been linked to an increased risk of early-onset Parkinson's disease. However, the pathophysiological mechanisms underlying parkinsonism remain poorly understood. Objective: The objective is to...
6.
Lattanzi S, Canafoglia L, Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, et al.
Epilepsia
. 2023 Dec;
64(11):2922-2933.
PMID: 38079181
Objective: This study aimed to explore the effectiveness of brivaracetam (BRV) according to baseline seizure frequency and past treatment history in subjects with focal epilepsy who were included in the...
7.
Fanella M, Valente G, Borrello L, Marinelli F, Bracaglia M, Di Marco O, et al.
Int J Neurosci
. 2023 Oct;
134(12):1606-1610.
PMID: 37855691
Sporadic Creutzfeldt-Jakob disease is characterized by rapid cognitive and neuropsychiatric impairment. The Heidenhain variant of Creutzfeldt-Jakob disease is known for isolated visual disturbance that precedes other features. Periodic sharp wave...
8.
Morano A, Orlando B, Fanella M, Cerulli Irelli E, Colonnese C, Quarato P, et al.
Epileptic Disord
. 2023 Jul;
PMID: 37430419
Musicogenic epilepsy (ME), a peculiar form of reflex epilepsy, represents a neurological rarity and yet another demonstration of the extraordinary power of music on the human brain. Despite the heterogeneity...
9.
Frascarelli M, Accinni T, Buzzanca A, Carlone L, Ghezzi F, Moschillo A, et al.
J Neuropsychol
. 2023 May;
17(3):564-583.
PMID: 37159847
Patients with the 22q11.2 deletion syndrome (DS) show an increased risk of developing a psychotic illness lifetime. 22q11.2DS may represent a reliable model for studying the neurobiological underpinnings of schizophrenia....
10.
Castellotti B, Canafoglia L, Freri E, Tappata M, Messina G, Magri S, et al.
Epilepsia Open
. 2023 Jan;
8(2):645-650.
PMID: 36719163
Variants of SEMA6B have been identified in an increasing number of patients, often presenting with progressive myoclonus epilepsy (PME), and to lesser extent developmental encephalopathy, with or without epilepsy. The...